Ethambutol hydrochloride

DRUG13 trials

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID), Pharmacia, Pfizer, Anderson Clinical Research, Abbott

Conditions

HIV InfectionsMycobacterium Avium-Intracellulare InfectionMycobacterium Avium-intracellular InfectionMycobacterium Avium-intracellulare InfectionTuberculosis

Phase 1

Effectiveness of Anti-HIV Therapy (HAART) in HIV-Infected Patients With Tuberculosis

CompletedNCT00004736

National Institute of Allergy and Infectious Diseases (NIAID)HIV Infections, Tuberculosis

Target: 44Updated: 2008-09-11

Phase 2

A Phase II/III Trial of Rifampin, Ciprofloxacin, Clofazimine, Ethambutol, and Amikacin in the Treatment of Disseminated Mycobacterium Avium Infection in HIV-Infected Individuals.

CompletedNCT00000641

National Institute of Allergy and Infectious Diseases (NIAID)HIV Infections, Mycobacterium Avium-intracellulare Infection

End: 1994-12-31Target: 90Updated: 2021-11-03

Evaluation of Treatment for Mycobacterium Avium Complex (MAC) Infection in HIV-Infected Patients

CompletedNCT00001039

National Institute of Allergy and Infectious Diseases (NIAID)HIV Infections, Mycobacterium Avium-intracellulare Infection

End: 2002-06-30Target: 24Updated: 2012-10-31

A Comparison of Three Drug Combinations Containing Clarithromycin in the Treatment of Mycobacterium Avium Complex (MAC) Disease in Patients With AIDS

CompletedNCT00001058

National Institute of Allergy and Infectious Diseases (NIAID)HIV Infections, Mycobacterium Avium-intracellulare Infection

End: 1999-01-31Target: 246Updated: 2021-11-01

Tolerance, Safety, and Activity of Rifapentine Alone and in Combination Therapy in AIDS Patients With Mycobacterium Avium Complex Bacteremia.

CompletedNCT00002192

Anderson Clinical ResearchHIV Infections, Mycobacterium Avium-Intracellulare Infection

Updated: 2005-06-24

Phase 3

A Randomized, Double-Blind, Comparative Study of Azithromycin Versus Clarithromycin in Combination With Ethambutol for the Treatment of Disseminated Mycobacterium Avium Complex (MAC) Infection in AIDs Patients

CompletedNCT00002140

PfizerHIV Infections, Mycobacterium Avium-intracellulare Infection

Updated: 2005-06-24

Study of Four Different Treatment Approaches for Patients Who Have Mycobacterium Avium Complex Disease (MAC) Plus AIDS

CompletedNCT00001047

National Institute of Allergy and Infectious Diseases (NIAID)HIV Infections, Mycobacterium Avium-intracellulare Infection

End: 1996-08-31Target: 400Updated: 2021-11-04

A Three-Arm Comparative Trial for the Treatment of MAC Bacteremia in AIDS: A Clarithromycin/Ethambutol Regimen Containing Rifabutin (450 Mg) or Rifabutin (300 Mg) or Placebo

CompletedNCT00002101

PharmaciaHIV Infections, Mycobacterium Avium-Intracellulare Infection

Target: 450Updated: 2005-06-24

The Treatment of Tuberculosis in HIV-Infected Patients

CompletedNCT00001033

National Institute of Allergy and Infectious Diseases (NIAID)HIV Infections, Tuberculosis

End: 1997-07-31Target: 650Updated: 2021-11-04

Phase 4

A Study of Rifabutin, Used Alone or With Ethambutol in the Prevention of Mycobacterium Avium Complex (MAC) Bacteremia in Patients With AIDS

CompletedNCT00002343

PharmaciaHIV Infections, Mycobacterium Avium-Intracellulare Infection

Target: 200Updated: 2005-06-24

Unknown Phase

A Prospective Study of Multidrug Resistance and a Pilot Study of the Safety of and Clinical and Microbiologic Response to Levofloxacin in Combination With Other Antimycobacterial Drugs for Treatment of Multidrug-Resistant Pulmonary Tuberculosis (MDRTB) in HIV-Infected Patients.

CompletedNCT00000796

National Institute of Allergy and Infectious Diseases (NIAID)HIV Infections, Tuberculosis

End: 1998-10-31Target: 525Updated: 2021-11-03

The Safety and Effectiveness of Clarithromycin Plus Ethambutol Used With or Without Clofazimine in the Treatment of MAC in Patients With AIDS

CompletedNCT00002331

AbbottHIV Infections, Mycobacterium Avium-intracellular Infection

Start: 1994-01-31End: 1995-03-31Updated: 2015-01-16

Metabolism of Antituberculosis Drugs in HIV-Infected Persons With Tuberculosis

CompletedNCT00000950

National Institute of Allergy and Infectious Diseases (NIAID)HIV Infections, Tuberculosis

Target: 50Updated: 2011-03-02